🔎 Trials Near Me

Hjem › Prostatakreft › Michigan › Grand Rapids

Kliniske studier for Prostatakreft i Grand Rapids, MI

19 studier for Prostatakreft søker deltakere på steder i og rundt Grand Rapids (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

RekruttererFase 1
  • START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

RekruttererFase 3
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

RekruttererFase 1/2
  • South Texas Accelerated Research Therapeutics, LLC (START), Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 25. sep. 2026 · NCT06800313

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

RekruttererFase 3
  • Cancer and Hematology Centers of Western Michigan ( Site 0005), Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06136650

A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

RekruttererFase 1
  • Start Midwest, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 25. sep. 2026 · NCT07746713

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

RekruttererFase 1
  • START Midwest, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 24. sep. 2026 · NCT07719361

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

RekruttererFase 1
  • BAMF Health Inc., Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07114601

Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])

RekruttererFase 2/3
  • BAMF Health, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 21. sep. 2026 · NCT07831824

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

RekruttererFase 3
  • Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT06925737

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

RekruttererFase 1/2
  • GSK Investigational Site, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 16. sep. 2026 · NCT07332455

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

RekruttererFase 1
  • BAMF Health, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 15. sep. 2026 · NCT07581184

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

RekruttererFase 3
  • BAMF Health, Grand Rapids
  • Corewell Health, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RekruttererFase 3
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

RekruttererFase 1/2
  • Research Site, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 2. sep. 2026 · NCT07192614

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

RekruttererFase 3
  • Research Site, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 26. aug. 2026 · NCT07611110

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

RekruttererFase 1/2
  • START, Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT07145255

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

RekruttererFase 1/2
  • START Midwest, Grand Rapids
Alder 18 og eldre · Alle kjønn · Oppdatert 11. des. 2025 · NCT06943521

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RekruttererFase 3
  • Spectrum Health at Butterworth Campus, Grand Rapids
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2025 · NCT03678025

Prostatakreft-studier i andre byer

Andre studier i Grand Rapids

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.